Related Experiment Video
Updated: Sep 9, 2025

08:47
Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions
Published on: July 26, 2024
2.5K
Microglia-Neuron Interactions in Alzheimer's Disease
Yujie Ma1, Xinyue Wang2,3, Minghuang Gao1
1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Current Neuropharmacology
|August 28, 2025
Summary
Microglia play a dual role in Alzheimer's disease (AD), a progressive neurodegenerative disorder. Understanding microglia-neuron interactions offers new therapeutic targets for AD.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) involves neuronal loss and dysfunction, leading to cognitive decline.
- Microglia, the brain's immune cells, are increasingly implicated in neuronal fate, but their precise role in AD pathogenesis is unclear.
- Existing AD hypotheses include amyloid cascade, tau protein, neuroinflammation, and metal ions.
Purpose of the Study:
- To review the role of microglia-neuron interactions in Alzheimer's disease pathogenesis.
- To explore microglia-mediated synaptic pruning and metabolic coupling in AD neuronal degeneration.
- To summarize microglia-neuron interactions within established AD pathogenic frameworks.
Main Methods:
- Literature review of scientific studies on microglia and Alzheimer's disease.
- Analysis of microglia's dual role as neuronal protectors and exacerbators of damage.
- Synthesis of findings related to synaptic pruning, metabolic coupling, and AD hallmarks.
Main Results:
- Microglia exhibit a bidirectional influence on neuronal health in AD.
- Excessive synaptic pruning by microglia contributes to neuronal loss.
- Microglia-neuron metabolic coupling is a key factor in AD neuronal degeneration.
- Microglia's role is integrated within amyloid, tau, neuroinflammation, and metal ion hypotheses.
Conclusions:
- Microglia-neuron interactions are critical in Alzheimer's disease neuronal degeneration.
- Microglia can both protect and harm neurons, depending on the context.
- Targeting microglia-neuron communication presents a novel therapeutic avenue for AD.
Related Concept Videos
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Glial Cells
88.8K
Overview
88.8K

